文献速递耳科与耳神经

人工耳蜗翻修手术原因与装置故障率分析

Evaluating Reasons for Revision Surgery and Device Failure Rates in Patients Who Underwent Cochlear Implantation Surgery.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2020-01-01

该队列研究回顾性分析2001年10月至2019年3月单中心925例人工耳蜗植入者,翻修率为4.6%(43/925),装置故障是最常见原因(65%)。10年累积手术生存率94.4%,装置生存率96.0%,不同制造商或装置模型间无显著差异。

要点

  • 翻修率为4.6%,装置故障占翻修原因的65%。
  • 10年累积手术生存率94.4%,装置生存率96.0%。
  • 不同制造商或装置模型间装置故障无显著差异。

核心结论

  • 植入装置长期安全稳定,不同装置类型或制造商间生存率无显著差异。
  • 装置故障是人工耳蜗翻修的主要原因,其次为皮瓣相关问题和内装置移位。

研究设计与样本

  • 回顾性队列研究,纳入2001年10月至2019年3月单中心925例人工耳蜗植入患者。
  • 装置生存分析以首次翻修手术为主要事件,观察终点为2019年6月1日。

主要发现

  • 43例(4.6%)接受翻修手术,装置故障28例(65%),皮瓣相关问题4例(9.3%),内装置移位4例(9.3%)。
  • 10年累积手术生存率94.4%,装置生存率96.0%。
  • 排除召回装置后,5年、10年、15年装置生存率分别为98.2%、97.7%、94.9%。

关键数值与推荐

  • 累积生存率风险比:Cochlear 1.67(95%CI 0.72-3.88),Advanced Bionics 1.67(95%CI 0.61-4.53),Med-El为参照。
  • 装置生存率风险比:Cochlear 1.65(95%CI 0.55-4.99),Advanced Bionics 1.93(95%CI 0.56-6.74),Med-El为参照。

临床怎么用

  • 咨询人工耳蜗候选者时可告知翻修率约4.6%,装置故障是主要原因。
  • 装置长期生存率高,不同品牌间无显著差异,选择装置时可参考但不必过度强调品牌差异。

局限性

  • 单中心回顾性研究,可能存在选择偏倚和信息偏倚。
  • 研究期间有装置召回,排除召回装置后的生存率数据需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Understanding the reasons for cochlear implant (CI) revision surgery and device failure rates is important for clinicians when counseling patients who are considering CI. OBJECTIVES: To analyze the revision surgery rate, reasons for revision surgery, and device failure and survival rates of different device models in recipients of CIs. DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, cochlear implants at Samsung Medical Center, a tertiary referral center, were retrospectively reviewed. Patients who underwent CI surgery from October 2001 to March 2019 were included. In the device survival analysis, the first revision surgery was considered the primary event, and the end point of observation was June 1, 2019. INTERVENTIONS: Therapeutic and rehabilitative CI surgery. MAIN OUTCOMES AND MEASURES: The revision surgery rate, reasons for revision surgery, and the failure and survival rates of different device models were analyzed. The Kaplan-Meier method and the log-rank test were used to present both the device survival and cumulative survival curves with rates. RESULTS: In this study, 43 of 925 patients with CIs (4.6%) underwent a revision surgery. Device failure was the most common reason (28 of 43 patients [65%]). Flap-associated problems and migration of the inner device were the next most important reasons (4 of 43 [9.3%] each). Overall, the 10-year cumulative survival rate of CI surgery was 94.4%, and the device survival rate was 96.0%. Thirteen different CI devices from 4 different manufacturers were implanted, and no meaningful differences in device failure were found among CI manufacturers or devices (hazard ratios for cumulative survival: Cochlear, 1.67 [95% CI, 0.72-3.88]; Advanced Bionics, 1.67 [95% CI, 0.61-4.53]; Med-El, reference; hazard ratios for device survival: Cochlear, 1.65 [95% CI, 0.55-4.99]; Advanced Bionics, 1.93 [95% CI, 0.56-6.74]; Med-El, reference). Several recalls were issued by manufacturers during the study period, and after excluding the recalled devices, the device survival rates for 5, 10, and 15 years were 98.2%, 97.7%, and 94.9%, respectively. CONCLUSIONS AND RELEVANCE: Generally, implanted devices remain safe and stable for a long time, and no significant differences in survival rates were found between device types or manufacturers. Device failure was the main reason for CI revision, followed by flap-associated problems and migration of the inner device.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Kim SY, Kim MB, Chung WH, et al. Evaluating Reasons for Revision Surgery and Device Failure Rates in Patients Who Underwent Cochlear Implantation Surgery. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 32134441. doi:10.1001/jamaoto.2020.0030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。